Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00592345 · ClinicalTrials.gov registry record · Phase 1

High-Dose Proton/Photon RT + Surgery of Sarcomas of the Thoracic, Lumbar Spine/Sacrum

A Phase 1 study, sponsored by Massachusetts General Hospital.

Completed
Registry status
Phase 1
Development phase
50
Enrollment target

NCT00592345: Completed Phase 1 study, sponsored by Massachusetts General Hospital.

NCT00592345 is a Phase 1 study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00592345, a Phase 1 study, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
Phase 1
Development phase
50 participants
Enrollment target

Study Summary

The purpose of this study is to test the effectiveness of high dose radiation administered by both proton and photon therapy. Radiation is an effective treatment for many types of tumors and it is thought that radiation alone, when given in much higher doses over a shorter period of time, may be more effective in controlling recurrence of sarcoma.

Interventions

  • RADIATION Proton Beam Radiation
  • RADIATION Photon Beam Radiation
  • RADIATION Interoperative radiation

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 1999-05
Est. Completion 2016-03
Phase Phase 1

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT00592345

The ClinicalTrials.gov registry entry for NCT00592345 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Proton Beam Radiation is the first listed.

NCT00592345 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00592345 about?

NCT00592345 is a clinical study titled "High-Dose Proton/Photon RT + Surgery of Sarcomas of the Thoracic, Lumbar Spine/Sacrum". The purpose of this study is to test the effectiveness of high dose radiation administered by both proton and photon therapy. Radiation is an effective treatment for many types of tumors and it is thought that radiation alone, when given in much higher doses over a shorter period of time, may be mor...

What is the current status of trial NCT00592345?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 50 participants. The study started on 1999-05. Estimated completion is 2016-03.

What interventions are being tested in trial NCT00592345?

The interventions under investigation include: Proton Beam Radiation (RADIATION), Photon Beam Radiation (RADIATION), Interoperative radiation (RADIATION).

Who is sponsoring clinical trial NCT00592345?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.